BCAL Diagnostics

BCAL Diagnostics Dividend

Dividend of BCAL Diagnostics (BDX.AX) as of Oct 17, 2026.

Dividend

0.00AUD

Last updated:

How much dividend does BCAL Diagnostics 2026 pay?

According to the latest status from October 2026, BCAL Diagnostics paid a total of 0.00 AUD per share in dividends within the last 12 months. With the current BCAL Diagnostics price of 0.08 AUD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical BCAL Diagnostics Dividends

Historical BCAL Diagnostics Dividends
PaydateDividend

The BCAL Diagnostics Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2019
0.00 AUD
Jan 1, 2020
0.00 AUD
Jan 1, 2021
0.00 AUD
Jan 1, 2022
0.00 AUD
Jan 1, 2023
0.00 AUD
Jan 1, 2024
0.00 AUD
Jan 1, 2025
0.00 AUD
Jan 1, 2026 (e)
0.00 AUD
The BCAL Diagnostics Dividend history
YEARDividendYoY
est0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—

Is the BCAL Diagnostics Dividend Safe?

BCAL Diagnostics has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding BCAL Diagnostics's Dividend Distributions

BCAL Diagnostics’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining BCAL Diagnostics's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

BCAL Diagnostics's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in BCAL Diagnostics’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

BCAL Diagnostics Stock analysis

What does BCAL Diagnostics do? BCAL Diagnostics Ltd, based in Sydney, Australia, operates in the Health Care sector within the Biotechnology industry. The company develops innovative blood screening tests for early breast cancer detection, focusing on a lipid biomarker-based approach known as the BCAL test. This technology complements existing imaging methods like mammograms and aims to support screening and monitoring for women of all ages and backgrounds. BCAL Diagnostics has partnered with Precion Inc. to advance clinical trials and regulatory approvals for its diagnostic solutions. BCAL Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BCAL Diagnostics stock

BCAL Diagnostics paid dividends every year for the past 0 years.

BCAL Diagnostics is assigned to the 'Health' sector.

The dividends of BCAL Diagnostics are distributed in AUD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — BCAL Diagnostics